Literature DB >> 24767184

Autoimmune blistering dermatoses as systemic diseases.

Snejina Vassileva1, Kossara Drenovska2, Karen Manuelyan2.   

Abstract

Autoimmune blistering dermatoses are examples of skin-specific autoimmune disorders that can sometimes represent the cutaneous manifestation of a multiorgan disease due to potential common pathogenic mechanisms. As soon as a distinct autoimmune blistering dermatosis is diagnosed, it is imperative to consider its potential systemic involvement, as well as the autoimmune and inflammatory conditions that are frequently associated with it. In paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome, the internal organs (particularly the lungs) are affected by the autoimmune injury. Pemphigus erythematosus may manifest with overlapping serologic and immunohistologic features of lupus erythematosus. In patients with bullous pemphigoid, there is a greater prevalence of neurologic disease, possibly caused by cross-reactivity of the autoantibodies with isoforms of bullous pemphigoid antigens expressed in the skin and brain. Anti-laminin 332 pemphigoid shows an increased risk for adenocarcinomas. Patients with anti-p200 pemphigoid often suffer from psoriasis. A rare form of pemphigoid with antibodies against the α5 chain of type IV collagen is characterized by underlying nephropathia. Particularly interesting is the association of linear IgA disease or epidermolysis bullosa acquisita with inflammatory bowel disease. Dermatitis herpetiformis is currently regarded as the skin manifestation of gluten sensitivity. Bullous systemic lupus erythematosus is part of the clinical spectrum of systemic lupus erythematosus, a prototypic autoimmune disease with multisystem involvement.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24767184     DOI: 10.1016/j.clindermatol.2013.11.003

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  10 in total

1.  Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis.

Authors:  Alex M Rokni; Marissa Ayasse; Adnan Ahmed; Lauren Guggina; Robert W Kantor; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2022-03-09       Impact factor: 3.017

2.  Nephrology pictures: pemphigus vulgaris and membranous nephropathy.

Authors:  Gisele Vajgel; Matheus R B Correia; Camila L C Costa; Luis H Sette
Journal:  J Nephrol       Date:  2021-10-15       Impact factor: 3.902

3.  Myocardial Damage in a Highly Suspected Case With Paraneoplastic Pemphigus: A Case Report and Literature Review.

Authors:  Xiao Du; Miao Zhang; Shilan Zhang; Feng Tian; Tie Wen; Ling Liu
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 4.  Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.

Authors:  Giovanni Paolino; Dario Didona; Giuseppe Magliulo; Giannicola Iannella; Biagio Didona; Santo Raffaele Mercuri; Elisa Moliterni; Michele Donati; Andrea Ciofalo; Guido Granata; Patricia Ranuzzi; Vincenzo Falasca; Stefano Calvieri
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

Review 5.  Adverse Immunologically Mediated Oral Mucosal Reactions to Systemic Medication: Lichenoid Tissue Reaction/Interface Dermatitis-Stomatitis, Autoimmune Vesiculobullous Disease, and IgE-Dependent and Immune Complex Reactions.

Authors:  R A G Khammissa; R Chandran; A Masilana; J Lemmer; L Feller
Journal:  J Immunol Res       Date:  2018-06-10       Impact factor: 4.818

6.  Vesiculobullous diseases in relation to lupus erythematosus.

Authors:  Suthinee Rutnin; Kumutnart Chanprapaph
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-09-04

Review 7.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

8.  Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis.

Authors:  Noritada Yoshikawa; Erika Matsubara; Motohisa Yamamoto; Hiroki Yamazaki; Masaaki Uehara; Masahiro Kamata; Hirotoshi Tanaka
Journal:  Intern Med       Date:  2020-07-07       Impact factor: 1.271

9.  Possible Role for Plasmacytoid Dendritic Cells in Pemphigus.

Authors:  Nehmat Ramadan; Mazen Kurban; Ossama Abbas
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

Review 10.  Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis.

Authors:  Dario Didona; Luca Fania; Biagio Didona; Rüdiger Eming; Michael Hertl; Giovanni Di Zenzo
Journal:  Int J Mol Sci       Date:  2020-03-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.